Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Gastrointestinal Tract
100%
Infliximab
100%
Basiliximab
100%
Chronic Graft-versus-host Disease (cGVHD)
100%
Graft-versus-host Disease (GvHD)
50%
Well-defined
25%
Overall Response Rate
25%
Poor Outcome
25%
Median Time
25%
New Agents
25%
Steroid Therapy
25%
Primary Disease
25%
Long-term Survivors
25%
Salvage Therapy
25%
Steroid-refractory
25%
Allogeneic Stem Cell Transplant
25%
Pharmacology, Toxicology and Pharmaceutical Science
Infliximab
100%
Acute Graft Versus Host Disease
100%
Basiliximab
100%
Diseases
50%
Steroid
50%
Retrospective Study
25%
Recurrent Disease
25%
Morbidity
25%
Chronic Graft Versus Host Disease
25%
Nursing and Health Professions
Basiliximab
100%
Infliximab
100%
Acute Graft Versus Host Disease
100%
Diseases
50%
Recurrent Disease
25%
Morbidity
25%
Steroid Therapy
25%
Salvage Therapy
25%
Steroid
25%
Chronic Graft Versus Host Disease
25%
Immunology and Microbiology
Acute Graft Versus Host Disease
100%
Infliximab
100%
Basiliximab
100%
Steroid
50%
Morbidity
25%
Chronic Graft Versus Host Disease
25%
Stem Cell Transplant
25%
Neuroscience
Basiliximab
100%
Infliximab
100%
Steroid
50%
Stem Cell
25%